Viewing Study NCT02549261

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 12:22 PM
Ignite Modification Date: 2026-02-25 @ 6:59 PM
Study NCT ID: NCT02549261
Status: UNKNOWN
Last Update Posted: 2015-09-15
First Post: 2015-08-18
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Nimotuzumab in Combination With Radiochemotherapy for Patients With Stage IIIA/IIIB Non-small Cell Lung Cancer
Sponsor: Biotech Pharmaceutical Co., Ltd.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Non-small Cell Lung Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None nimotuzumab View
None non-small cell lung cancer View
None radiochemotherapy View
None stage IIIA/IIIB non-small cell lung cancer View